Comment
doi: 10.1182/blood.2020007671.
MLL-menin and FLT3 inhibitors team up for AML
Affiliations
- PMID: 33211832
- DOI: 10.1182/blood.2020007671
Item in Clipboard
Comment
MLL-menin and FLT3 inhibitors team up for AML
Blood.
.
Free article
No abstract available
Comment on
-
Synergistic targeting of FLT3 mutations in AML via combined menin-MLL and FLT3 inhibition.Blood. 2020 Nov 19;136(21):2442-2456. doi: 10.1182/blood.2020005037. Blood. 2020. PMID: 32589720 Free PMC article.
Similar articles
-
The heterogeneity of pediatric MLL-rearranged acute myeloid leukemia.Leukemia. 2011 Aug;25(8):1239-48. doi: 10.1038/leu.2011.90. Epub 2011 May 13. Leukemia. 2011. PMID: 21566656 Review.
-
Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML.Leukemia. 2010 Aug;24(8):1528-32. doi: 10.1038/leu.2010.124. Epub 2010 Jun 3. Leukemia. 2010. PMID: 20520634 No abstract available.
-
FLT3-ITD and MLL-PTD influence the expression of MDR-1, MRP-1, and BCRP mRNA but not LRP mRNA assessed with RQ-PCR method in adult acute myeloid leukemia.Ann Hematol. 2014 Apr;93(4):577-93. doi: 10.1007/s00277-013-1898-7. Epub 2013 Sep 13. Ann Hematol. 2014. PMID: 24030729 Clinical Trial.
-
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.N Engl J Med. 2008 May 1;358(18):1909-18. doi: 10.1056/NEJMoa074306. N Engl J Med. 2008. PMID: 18450602
-
Treatment of Acute Myeloid Leukemia with the FLT3 Gene Mutation.Curr Oncol Rep. 2017 Mar;19(3):21. doi: 10.1007/s11912-017-0573-x. Curr Oncol Rep. 2017. PMID: 28283965 Review.
Cited by
-
Advances in therapeutic options for newly diagnosed, high-risk AML patients.Ther Adv Hematol. 2021 May 5;12:20406207211001138. doi: 10.1177/20406207211001138. eCollection 2021. Ther Adv Hematol. 2021. PMID: 33995985 Free PMC article. Review.
-
Targeting FLT3 Mutation in Acute Myeloid Leukemia: Current Strategies and Future Directions.Cancers (Basel). 2023 Apr 15;15(8):2312. doi: 10.3390/cancers15082312. Cancers (Basel). 2023. PMID: 37190240 Free PMC article. Review.
-
Application of omics in the diagnosis, prognosis, and treatment of acute myeloid leukemia.Biomark Res. 2024 Jun 10;12(1):60. doi: 10.1186/s40364-024-00600-1. Biomark Res. 2024. PMID: 38858750 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
